GA
ABPI

Geneva Advisors’s Accentia Biopharmaceuticals ABPI Stock Holding History

Geneva Advisors’s Portfolio ABPI Stock Details ABPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,925
Closed – – 781
2016
Q2 		$0 Hold
10,925
– – ﹤0.01% 775
2016
Q1 		$0 Hold
10,925
– – ﹤0.01% 758
2015
Q4 		$0 Buy
+10,925
New – ﹤0.01% 713

Geneva Advisors's ABPI Position: Q3 2016 in Review

Geneva Advisors sold out of Accentia Biopharmaceuticals (ABPI) in Q3 2016, closing a stake of 10,925 shares.

Geneva Advisors first reported a position in ABPI in Q4 2015 and held it in 3 quarters. The position peaked at $0 in Q2 2016. 2 funds tracked by Wall St. Rank hold ABPI as of Q3 2016.

  • Geneva Advisors reported no remaining Accentia Biopharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Geneva Advisors sold 10,925 Accentia Biopharmaceuticals shares in Q3 2016.
  • Geneva Advisors first reported a position in Accentia Biopharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Geneva Advisors's Accentia Biopharmaceuticals position peaked at $0 in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Accentia Biopharmaceuticals as of Q3 2016.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.